The possible partnership with a large pharma in taking the...

The possible partnership with a large pharma in taking the ConneQt Band to market is big news.
If we have been discussing terms on ConneQt Band with a large pharma, I'm pretty confident who it would be. CardieX and Bayer AG have recently been in discussions and signing contracts on extending use of our Sphygmcor Technology in their clinical trials ... maybe across several devices !

I also recall in one of Craig's recent interviews he mentioned that there has been strong interest for a FDA cleared wearable for measuring BP in current and upcoming clinical trials ... I didn't pay much attention at the time, but in retrospect it may have been a key comment.

From the last quarterly :

Clinical Trial Expansion with Bayer AG .

This quarter Bayer AG and CardieX entered into a new Amended Agreement for both the leaseof ATCOR devices and the provision of expanded data management services for Bayer’s‘CONCORD’ clinical trial that is being conducted in patients with chronic diseases - diabetesand/or hypertension.This was a second material expansion of the current CONCORD trial, which commenced in2017 with an initial contract value of $US756K. The original agreement for the trial wasexpanded in March 2020 to a contract value of $US1.53M (refer: ASX 26 March 2020).The latest increase now brings the total contract value to an excess of $US2m (AU$2.76m)(refer: ASX 25 August 2021). The increase in contract value relates to additional incrementalpatient visits over 2 additional countries. The CONCORD trial now has ATCOR technology beingused at 84 sites across 13 counties for this contract alone.The contract amendment and expansion with Bayer validates the capabilities of CardieX’sFDA-cleared SphygmoCor® technology – the same technology proposed to be used in ourCONNEQT Band and upcoming smart home health devices.The continued demand for contracted clinical trials using the ATCOR XCEL device and datamanagement services continues to add significant new incremental revenue to the Company.

Such a relationship would change the game a bit !

IMO.